Advances in Clinical Chemistry: Volume 80

ISBN-13: 9780128120750 / Angielski / Twarda / 2017 / 272 str.

Gregory S. Makowski

Opis

Advances in Clinical Chemistry, Volume 80, the latest installment in this internationally acclaimed series, covers a variety of topics relating to the topic. Users will find new chapters on Triglycerides Revisited to the Serial, PCR-Based Detection Methods for Single Nucleotide Polymorphism or Mutation: Real-Time PCR and its Substantial Contribution Towards Technological Refinement, Advances in Circulating Tumor DNA Analysis, Advances in Molecular Diagnosis of Malaria, and Rapid Assessment of Drugs of Abuse. This series contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists who discuss the latest and most up-to-date technologies related to the field of clinical chemistry. Users of this series will find a resource that is considered to be the benchmark for novel analytical approaches in the clinical laboratory.

• Provides the most up-to-date technologies in Clinical Chemistry and Clinical Laboratory Science
• Authored by world renowned clinical laboratory scientists, physicians and research scientist
• Presents the international benchmark for novel analytical approaches in the clinical laboratory

Spis treści

1. Triglycerides Revisited to the SerialP.R.N. Viecili, B. da Silva, G.E. Hirsch, F.G. Porto, M.M. Parisi, A.R. Castanho, M. Wender and J.Z. Klafke2. PCR-Based Detection Methods for Single Nucleotide Polymorphism or Mutation: Real-Time PCR and its Substantial Contribution Towards Technological RefinementK. Matsuda3. Advances in Circulating Tumor DNA AnalysisS. Perakis, M. Auer, J. Belic and E. Heitzer4. Advances in Molecular Diagnosis of MalariaZ. Zhenz and Z. Cheng5. Rapid Assessment of Drugs of AbuseJ.R.Wiencek, J. Colby and J.H. Nichols6. Infections: A Possible Risk Factor for Type 2 DiabetesS. Chakraborty, R. Bhattacharyya and D. Banerjee

O autorze

Dr Gregory S Makowski is a board certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in his joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President and Chief Scientific Officer for Clinical Laboratory Partners in Newington CT, USA.